John F. Gilmer
- Molecular Biology
- Oncology top 10%
- Organic Chemistry top 10%
- Pharmacology top 5%
- Surgery
- Co-authors
- Carlos MedinaShane O’SullivanJohn M. ClancyAna Luı́sa Simplı́cioMarek W. RadomskiJohn WalshAideen LongRuchika Sharma
- Topics
- Cholinesterase and Neurodegenerative Diseases (12 papers)Computational Drug Discovery Methods (10 papers)Protease and Inhibitor Mechanisms (9 papers)
- Partner nations
- IrelandCanadaUnited States
In The Last Decade
John F. Gilmer
68 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 115
- Molecular Biology 532
- Oncology 337
- Organic Chemistry 317
- Pharmacology 267
- Surgery 154
Countries citing papers authored by John F. Gilmer
This map shows the geographic impact of John F. Gilmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Gilmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Gilmer more than expected).
Fields of papers citing papers by John F. Gilmer
This network shows the impact of papers produced by John F. Gilmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Gilmer. The network helps show where John F. Gilmer may publish in the future.
Co-authorship network of co-authors of John F. Gilmer
This figure shows the co-authorship network connecting the top 25 collaborators of John F. Gilmer. A scholar is included among the top collaborators of John F. Gilmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. Gilmer. John F. Gilmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | 3 | |
| 4 | 10 | |
| 5 | 93 | |
| 6 | 10 | |
| 7 | 16 | |
| 8 | 19 | |
| 9 | 2 | |
| 10 | 10 | |
| 11 | 53 | |
| 12 | 45 | |
| 13 | 16 | |
| 14 | 26 | |
| 15 | 16 | |
| 16 | 4 | |
| 17 | 9 | |
| 18 | 14 | |
| 19 | 32 | |
| 20 | 20 |
About John F. Gilmer
John F. Gilmer is a scholar working on Pharmacology, Filtration and Separation and Cancer Research, having authored 68 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (12 papers), Computational Drug Discovery Methods (10 papers) and Protease and Inhibitor Mechanisms (9 papers). The work is most often cited by research in Pharmacology (267 citations), Oncology (337 citations) and Organic Chemistry (317 citations). John F. Gilmer has collaborated with scholars based in Ireland, Canada and United States. Frequent co-authors include Carlos Medina, Shane O’Sullivan, John M. Clancy, Ana Luı́sa Simplı́cio, Marek W. Radomski, John Walsh, Aideen Long, Ruchika Sharma, Justin J. Perry and Anthony P. Davis. Their work appears in journals such as The Journal of Physiology, Biochemical Journal and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.